Erika Wachs Appointed Director of Business Development at ABL, Inc.
June 20, 2024
| BioBuzz’s mission is simple: to be more connected. Our regionally-focused storytelling, programs, events and experiences connect, amplify and create impact across the life science workforce in growing biohubs. Submit your People On The Move (free and ongoing) to showcase your company’s growth by promoting your new hires and recent promotions. |
ABL, Inc., a prominent biotech CDMO headquartered in Rockville, MD, has announced the appointment of Erika Wachs as its new Director of Business Development. ABL, Inc. specializes in contract development and manufacturing services, playing a critical role in advancing vaccines and viral vector therapies through preclinical and clinical development. ABL provides its clients with a 60+ year track record, expertise in a breadth of vaccines and viruses, fully integrated translational solutions, and GMP biomanufacturing and fill finish services. With over 25 years of experience in the biopharmaceutical industry, Wachs brings extensive expertise, including, providing strategic leadership, delivering innovative solutions and services, forging strategic client partnerships, developing sales organizations for exceptional client outcomes, and driving operational excellence.
Wachs expressed her excitement about joining ABL, stating, “We have a wide breadth of offerings and a fantastic team of scientific problem solvers, allowing us to perfectly align our biomanufacturing and translational services with the specific needs of our clients in mind. At ABL, I have the opportunity to learn something new every day from each new client and provide the critical partnership and services to deliver these vital therapies to patients in need”.
About Erika Wachs
Wachs holds a Bachelor’s Degree in Chemical Engineering from Worcester Polytechnic Institute and a Master’s Degree in Materials Science from the University of Delaware. She began her career as a process development engineer at W. L. Gore & Associates before transitioning to biopharmaceutical business development. Over the years, she has held key business development roles at various companies, culminating in her current position at ABL.
Erika’s core competencies include growing strategic global accounts, strategic planning, senior-level relationship building, team development, and implementing complex customer solutions and services. She collaborates with technical SMEs, cross-functional leadership counterparts, and strategic marketing teams to bring unique technical solutions and services to market. Erika’s mission is to improve the human condition by enabling and accelerating life-saving and life-changing therapies.
About ABL Inc.
With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world’s most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients’ team – helping them advance today’s ideas into tomorrow’s medicines. ABL is a subsidiary of the Institut Mérieux from Lyon, France.
ABL’s CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from early stage to market, and contributes to the success of its clients’ immunotherapy innovations, including gene therapies, immunotherapies, viral vaccines, recombinant protein vaccines, and more. ABL’s CDMO services include bulk drug substance, fill/finish of drug products, process and assay development, and bioanalytical testing.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
